title: [The 1188 A/C ILI2B gene polymorphism in patients with multiple sclerosis and in healthy subjects of Tomsk region].
abstract: Multiple sclerosis (MS) is a multifactorial and polygenic disorder of the central nervous system, its development being under strong influence of T-helpers type I which produce anti-inflammation cytokines. Interleukin 12 (IL12) plays a key role in such polarization of the immune response. Genotyping for polymorphism of the IL12B gene in the 3'-untranslated region, coding for the p40(IL12B) subunit, has been carried out in 62 patients with MS and 129 healthy controls. The C/C genotype frequency was twice higher in patients as compared to the controls (33.9% and 17.4%, respectively). The allele C in patients was associated with shorter duration of the first remission (p = 0.028) which was 1.79 +/- 0.28 in those with the C allele and 3.27 +/- 0.68 in other patients. Mean rate of relapses per year was also higher (p = 0.079) in patients with the C allele (0.96 +/- 0.11) comparing with the A allele (0.72 +/- 0.11). During the treatment with copaxone, a trend towards increasing of the time before the first relapse was observed in patients with the C allele. An analysis of immunologic indices revealed that they changed in opposite directions depending on the gene variant. The C-allele is suggested to have relation both to liability to MS and to its pathogenesis.
authors.forename: V M
authors.initials: VM
authors.lastname: Alifirova
authors.forename: Iu Iu
authors.initials: IuIu
authors.lastname: Orlova
authors.forename: S A
authors.initials: SA
authors.lastname: Babenko
authors.forename: A A
authors.initials: AA
authors.lastname: Rudko
authors.forename: V P
authors.initials: VP
authors.lastname: Puzyrev
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D000483:Alleles; D002391:Catchment Area, Health; D005260:Female; D015870:Gene Expression / Q000235:genetics*; D005838:Genotype; D000068717:Glatiramer Acetate; D006304:Health Status; D006801:Humans; D053762:Interleukin-12 Subunit p40 / Q000235:genetics*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000235:genetics*; D010455:Peptides / Q000627:therapeutic use; D011110:Polymorphism, Genetic / Q000235:genetics*; D012426:Russia
chemical_list: D000276:Adjuvants, Immunologic; D053762:Interleukin-12 Subunit p40; D010455:Peptides; D000068717:Glatiramer Acetate